Alligator Bioscience AB
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Alligator Bioscience AB
Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs focused on the CD40 receptor. Its drug candidate mitazalimab, is currently in preparation for Phase 3 development, and has previously presented unprecedented survival data at 18-months follow up in first-line metastatic pancreatic cancer patients in the Phase 2 trial OPTIMIZE-1.
/ 
Others were interested in
Frequently asked questions
To buy Alligator Bioscience AB stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Alligator Bioscience AB by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Alligator Bioscience AB is ATORX:xome. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Alligator Bioscience AB has its primary listing on NASDAQ OMX Stockholm. You can trade Alligator Bioscience AB with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Alligator Bioscience AB is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Alligator Bioscience AB as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Alligator Bioscience AB.